Who
Damien McDonald
Chief Executive Officer
Company insider
Files Form 4 as: Chief Executive Officer, Enovis; CEO, LivaNova.
In numbers
- Trades disclosed
- 151
- Buys
- 2
- Sells
- 15
- Bought
- $699K
- Sold
- $3.9M
- Companies
- 2
- Companies where not an officer
- 0
- First trade
- 4 Nov 2016
- Last trade
- 4 Sep 2026
- Last filed
- 4 Sep 2026
Companies traded
Activity over time
1 Nov 2024 – 1 Oct 2026
Buys above the line, sells below, each month.
Every trade
| Traded | Company | What | Amount | |
|---|---|---|---|---|
| 4 Sep 2026filed 4 Sep 2026 | ENOV EnovisMedical Devices | SEC FORM 4 Bought | $250K13,035 at $19.15 | filing |
| 4 Sep 2026filed 4 Sep 2026 | ENOV EnovisMedical Devices | SEC FORM 4 Bought | $250K13,035 at $19.15 | filing |
| 12 May 2026filed 14 May 2026 | ENOV EnovisMedical Devices | SEC FORM 4 Code F | $328K12,634 at $25.99 | filing |
| 12 May 2026filed 14 May 2026 | ENOV EnovisMedical Devices | SEC FORM 4 Code F | $328K12,634 at $25.99 | filing |
| 9 Mar 2026filed 10 Mar 2026 | ENOV EnovisMedical Devices | SEC FORM 4 Code A | —143,923 at $0.00 | filing |
| 9 Mar 2026filed 10 Mar 2026 | ENOV EnovisMedical Devices | SEC FORM 4 Code A | —143,923 at $0.00 | filing |
| 11 Sep 2025filed 11 Sep 2025 | ENOV EnovisMedical Devices | SEC FORM 4 Bought | $200K6,457 at $30.97 | filing |
| 12 May 2025filed 14 May 2025 | ENOV EnovisMedical Devices | SEC FORM 4 Code A | —96,296 at $0.00 | filing |
| 30 Mar 2023filed 28 Apr 2023 | LIVN LivaNovaMedical Devices | SEC FORM 4 Sold | $94K2,220 at $42.55 | filing |
| 30 Mar 2023filed 3 Apr 2023 | LIVN LivaNovaoption or derivative · Medical Devices | SEC FORM 4 Code M | —3,213 at $0.00 | filing |
| 30 Mar 2023filed 3 Apr 2023 | LIVN LivaNovaoption or derivative · Medical Devices | SEC FORM 4 Code M | —8,607 at $0.00 | filing |
| 30 Mar 2023filed 3 Apr 2023 | LIVN LivaNovaoption or derivative · Medical Devices | SEC FORM 4 Code M | —5,119 at $0.00 | filing |
| 30 Mar 2023filed 3 Apr 2023 | LIVN LivaNovaoption or derivative · Medical Devices | SEC FORM 4 Code M | —4,571 at $0.00 | filing |
| 30 Mar 2023filed 3 Apr 2023 | LIVN LivaNovaoption or derivative · Medical Devices | SEC FORM 4 Code A | —38,416 at $0.00 | filing |
| 30 Mar 2023filed 3 Apr 2023 | LIVN LivaNovaoption or derivative · Medical Devices | SEC FORM 4 Code A | —19,208 at $0.00 | filing |
| 30 Mar 2023filed 3 Apr 2023 | LIVN LivaNovaoption or derivative · Medical Devices | SEC FORM 4 Code A | —19,208 at $0.00 | filing |
| 30 Mar 2023filed 3 Apr 2023 | LIVN LivaNovaoption or derivative · Medical Devices | SEC FORM 4 Code A | —38,416 at $0.00 | filing |
| 30 Mar 2023filed 3 Apr 2023 | LIVN LivaNovaoption or derivative · Medical Devices | SEC FORM 4 Code A | —81,613 at $0.00 | filing |
| 30 Mar 2023filed 3 Apr 2023 | LIVN LivaNovaMedical Devices | SEC FORM 4 Code M | —3,213 at $0.00 | filing |
| 30 Mar 2023filed 3 Apr 2023 | LIVN LivaNovaMedical Devices | SEC FORM 4 Code F | $65K1,511 at $42.71 | filing |
News
Enovis (NYSE:ENOV) and electroCore (NASDAQ:ECOR) Head to Head SurveyENOV · themarketsdaily.com · 11 Oct 2026
0 headlines in the last 90 days name Damien McDonald; 1 article from the last 14 days about the 1 company they traded most, at most three about any one of them.